DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "North America Clot Management Devices Market (2016-2022)" report to their offering.
North America captures maximum share of the Clot Management Devices market with the high acceptance of technologically advanced products coupled with higher awareness among the customers. As per the World Health Organization (WHO), more than 17 million people die annually from cardiovascular diseases. The main reason for cardiovascular diseases are increasing consumption of tobacco products, physical inactivity, changes in diet plans, air pollution and work pressure. Blood Clotting also known as coagulation is the body's response to an injury to prevent bleeding.
However, a clot can be harmful when it forms abnormal flows through the vessels. The excessive formation of clots in the blood leads to different diseases such as brain stroke, heart attack and severe leg pain. Blood Clot forms in one or more veins located deep inside a human body would lead to Deep Vein Thrombosis (DVT) and could damage an organ completely. Clot Management devices are used for the treatment of coronary thrombosis, periphery artery, arteriovenous, neurovascular and DVT.
Key Topics Covered:
1. Market Scope & Methodology
2. Executive Summary
3. Market Overview
4. North America Clot Management Market by Product
5. North America Clot Management Market by End User
6. North America Clot Management Market by Country
7. Company Profiles
- Teleflex Inc.
- Edwards Lifesciences Corporation
- Medtronic Plc
- Boston Scientific Corporation
- Lemaitre Vascular, Inc.
- Straub Medical AG
- Cook Medical Inc.
Johnson & Johnson
For more information about this report visit http://www.researchandmarkets.com/research/wqlqh5/north_america